Articles

Ashwagandha is the star plant on the supplement shelves: it promises calm, less stress and better sleep. The evidence shows a small effect on anxiety and cortisol, while several European agencies have raised red flags over the liver and the thyroid. Here is what is known, what is not, and where it stands from a regulatory point of view in Spain.

Low-dose aspirin is a medicine cabinet classic, but the science has gradually refined when it genuinely protects you and when the bleeding risk eats up the benefit. Here's what the trials and guidelines say, without the scaremongering.

Phytoestrogens, isoflavones, vitamins, omega-3… the menopause supplement shelf is enormous, but the evidence is more modest than the packaging suggests. Here's what the science says, what the law allows a label to claim, and why a food supplement is never a medicine.

You notice more hair than usual on the pillow or in the shower and it gives you a fright. Telogen effluvium is the most common cause of diffuse hair loss: it appears after physical stress, childbirth or a hormonal change, and in most cases it resolves on its own. Here is why it happens, what the evidence says and what is actually known.

Metabolic syndrome is not a single disease but a cluster of risk factors that tend to travel together: waist, blood sugar, blood pressure and blood fats. Here is what the evidence says, how common it is in Spain and what genuinely works to lower the risk.

Testosterone boosters, maca, tribulus, zinc, ashwagandha… the shelves are full of promises. We take a calm look at what the science actually supports, what is pure marketing and why it matters to tell a genuine deficiency apart from a passing trend.

Survodutide is an investigational drug that activates two receptors at once: the GLP-1 receptor and the glucagon receptor. It is in advanced trials for obesity and for liver disease, but it is not yet authorised in Spain. Here is what the data actually show.

We explain how a telemedicine service for menopause works in Spain and what the law requires of any health website offering consultations: authorisation of the clinic, transparency and clear limits on advertising prescription-only medicines.

The route a drug takes into the body changes how much of it reaches the bloodstream, and how fast. Here we explain what bioavailability is, why the route matters, and what the evidence says about the idea that injections are always "stronger".

Biotin, hair complexes, plant extracts: every month a new bottle appears promising to stop hair loss. We look at what the evidence really says, what effect nutraceuticals have and why biotin can give you a scare on a blood test.

Alopecia areata is not the same as ordinary balding. We explain what defines it, why it happens, how it is diagnosed and how it differs from androgenetic alopecia, based on the evidence available today.

Vaginal dryness and pain during sex are common symptoms after the menopause and form part of what is known as genitourinary syndrome. We explain why it happens, what the evidence says and why effective treatment exists even though many women never seek help.
Online medical assessment, prescription when appropriate and 1:1 follow-up with this team.